MTF1 and bladder transitional cell carcinoma: The results indicated that the expression of MTF1 in BLCA, BRCA, KIRC, LIHC, OV, pheochromocytoma and paraganglioma (PCPG), READ, PRAD, SKCM, and STAD showed significant differences among different immune subtypes (P < 0.05) (Fig. 10B-J).